CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Sell
47
EBR.B Quote, Financials, Valuation and Earnings
Last price:
$8.16
Seasonality move
:
2.59%
Day range:
$8.10 - $8.26
52-week range:
$5.98 - $9.28
Dividend yield:
7.83%
P/E ratio:
10.18x
P/S ratio:
2.58x
P/B ratio:
0.95x
Volume:
9.7K
Avg. volume:
30.1K
1-year change:
-7.15%
Market cap:
$18.7B
Revenue:
$7.5B
EPS (TTM):
$0.82
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Centrais Eletricas Brasileiras SA has -- downside to fair value with a price target of -- per share.
EBR.B vs. S&P 500
-
Over the past 5 trading days, Centrais Eletricas Brasileiras SA has underperformed the S&P 500 by -1.94% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Centrais Eletricas Brasileiras SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Centrais Eletricas Brasileiras SA has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Centrais Eletricas Brasileiras SA reported revenues of $2.1B.
Earnings Growth
-
Centrais Eletricas Brasileiras SA has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Centrais Eletricas Brasileiras SA reported earnings per share of $0.08.
Enterprise value:
25.6B
EV / Invested capital:
--
Price / LTM sales:
2.58x
EV / EBIT:
8.30x
EV / Revenue:
3.45x
PEG ratio (5yr expected):
0.10x
EV / Free cash flow:
15.52x
Price / Operating cash flow:
11.59x
Enterprise value / EBITDA:
6.69x
Gross Profit (TTM):
$3.3B
Return On Assets:
3.69%
Net Income Margin (TTM):
25.44%
Return On Equity:
8.7%
Return On Invested Capital:
5.44%
Operating Margin:
78.57%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $6.6B | $7.4B | $7.4B | $2B | $2.1B | |
| Gross Profit | $5.6B | $6.3B | $6.1B | $3.5B | $3.6B | |
| Operating Income | $1.2B | $2B | $2.3B | -$50M | $449.2M | |
| EBITDA | $2.4B | $2.4B | $3.8B | -$41.1M | $625.3M | |
| Diluted EPS | $0.41 | $0.40 | $0.82 | $0.08 | $0.08 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $8.6B | $7.1B | $9.4B | $9.9B | $10.4B | |
| Total Assets | $34.4B | $33.8B | $51.1B | $55B | $46.9B | |
| Current Liabilities | $5.3B | $4.3B | $5B | $5.6B | $5.1B | |
| Total Liabilities | $20.2B | $20.1B | $30.1B | $31.9B | $27.2B | |
| Total Equity | $14.2B | $13.7B | $21B | $23.2B | $19.7B | |
| Total Debt | $9.2B | $8.1B | $11.4B | $12.7B | $12.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1B | $1.6B | $2.3B | $318.9M | $1.1B | |
| Cash From Investing | -$4.8B | $165.7M | -$1.6B | -$60.2M | -$1B | |
| Cash From Financing | $5.8B | -$1.4B | $1.8B | -$1.9B | $919.8M | |
| Free Cash Flow | -$5.5B | $824.3M | $1.7B | -$39.3M | $778.3M | |
EBR.B
Sector
Market Cap
$18.7B
--
Price % of 52-Week High
89.76%
--
Dividend Yield
7.83%
--
Shareholder Yield
--
--
1-Year Price Total Return
-4.25%
--
Beta (5-Year)
0.801
--
Dividend yield:
7.83%
Annualized payout:
$0.65
Payout ratio:
--
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$8.43
200-day SMA
Buy
Level
$7.38
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$8.10
Relative Strength Index (RSI14)
Buy
Level
52.50
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-36.5759
50-day SMA
Buy
Level
$7.78
MACD (12, 26)
Buy
Level
0.20
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8319)
Sell
CA Score
(Annual)
Level (-0.497)
Buy
Beneish M-Score
(Annual)
Level (-2.6639)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.0994)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Centrais Eletricas Brasileiras SA is engaged in the generation, transmission, and commercialization of electricity in Brazil. The company operates a portfolio of wind, thermal, hydro, and nuclear power plants located throughout the country. Its segments are Generation which consists of the generation of electric energy and the sale of energy to distribution companies and free consumers, and commercialization; Transmission which consists of the transmission of electric energy; and Administration activities mainly represent the Company’s cash management, the management of the compulsory loan, and the management of business in SPEs, and others.
Stock Forecast FAQ
In the current month, EBR.B has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EBR.B average analyst price target in the past 3 months is --.
-
Where Will Centrais Eletricas Brasileiras SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Centrais Eletricas Brasileiras SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Centrais Eletricas Brasileiras SA?
Analysts are divided on their view about Centrais Eletricas Brasileiras SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Centrais Eletricas Brasileiras SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Centrais Eletricas Brasileiras SA's Price Target?
The price target for Centrais Eletricas Brasileiras SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EBR.B A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Centrais Eletricas Brasileiras SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of EBR.B?
You can purchase shares of Centrais Eletricas Brasileiras SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Centrais Eletricas Brasileiras SA shares.
-
What Is The Centrais Eletricas Brasileiras SA Share Price Today?
Centrais Eletricas Brasileiras SA was last trading at $8.16 per share. This represents the most recent stock quote for Centrais Eletricas Brasileiras SA. Yesterday, Centrais Eletricas Brasileiras SA closed at $8.18 per share.
-
How To Buy Centrais Eletricas Brasileiras SA Stock Online?
In order to purchase Centrais Eletricas Brasileiras SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
76
FARO alert for May 8
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
